RESUMO
Sepsis is a heterogeneous disease caused by an infection stimulus that triggers several complex local and systemic immuno-inflammatory reactions, which results in multiple organ dysfunction and significant morbidity and mortality. The diagnosis of sepsis is challenging because there is no gold standard for diagnosis. As a result, the clinical diagnosis of sepsis is ever changing to meet the clinical and research requirements. Moreover, although there are many novel biomarkers and screening tools for predicting the risk of sepsis, the diagnostic performance and effectiveness of these measures are less than satisfactory, and there is insufficient evidence to recommend clinical use of these new techniques. As a consequence, diagnostic criteria for sepsis need regular revision to cope with emerging evidence. This review aims to present the most updated information on diagnosis and early recognition of sepsis. Recommendations for clinical use of different diagnostic tools rely on the Grades of Recommendation Assessment, Development and Evaluation (GRADE) framework. Because most of the studies were observational and did not allow a reliable assessment of these tools, a two-step inference approach was employed. Future trials need to confirm or refute a particular index test and should directly explore relevant patient outcome parameters.
RESUMO
OBJECTIVE: The objective of the study was to reduce the ventilator-associated pneumonia (VAP) incidence rates through a rational prevention program. DESIGN: The study was a non-controlled clinical trial with a set of interventions in mechanically ventilated patients from April 2006 until June 2008. Pneumonia rates were analyzed as time series and their mean risks of development were compared before and after the interventions with a non-concurrent cohort using the same time frame (January 2004-March 2006). SETTING: The study was conducted in a 14-bed medical intensive care unit of private general hospital in Rio de Janeiro, Brazil. PARTICIPANTS: The study included invasively ventilated patients (n = 224; intervention group) compared with 294 controls (historical cohort). INTERVENTIONS: An educational module about VAP prevention was introduced at the start of the trial (April 2006). A bundle checklist was used daily concomitantly with a standardized oral care in all patients afterwards. Main outcome measure The main outcome measure was reduction in VAP incidence rates. RESULTS: The observed mean rate before the intervention was 18.6 ± 7.8/1000 ventilator-days (95% CI 8.7-14.9), decreasing to 11.8 ± 7.8/1000 ventilator-days (95% CI 15.5-21.7) (P = 0.002) after the interventions. Under the adoption of non-informative prior distributions for the parameters of the proposed statistical model, there was a 70% posterior probability in favor of the hypothesis of risk reduction associated with the interventions, regardless their seasonality or secular trends. There was a 38% relative risk reduction. CONCLUSIONS: A reduction in VAP rates and on their risk after a set of preventive tools was observed. However, some other co-interventions not related to the primary interventions may have contributed to these results.
Assuntos
Pneumonia Associada à Ventilação Mecânica/prevenção & controle , Idoso , Idoso de 80 Anos ou mais , Brasil/epidemiologia , Feminino , Hospitais Gerais , Humanos , Incidência , Masculino , Recursos Humanos em Hospital/educação , Pneumonia Associada à Ventilação Mecânica/epidemiologia , Respiração Artificial/efeitos adversos , Respiração Artificial/métodosRESUMO
CONTEXT: The renin-angiotensin system is activated in patients with acute severe heart failure, and increased levels of angiotensin II could contribute to microcirculatory defects in these patients. OBJECTIVE: To evaluate the microcirculatory effects of angiotensin II antagonists in critically ill patients with severe heart failure. METHODS: After Ethics Committee approval and signed consent, we conducted a prospective observational study using sidestream darkfield (SDF) imaging to evaluate changes in the sublingual microcirculation of 25 adult patients with severe heart failure (ejection fraction < 40% or cardiac index < 2.5 L/min.m2) who received angiotensin inhibitors during their ICU stay. SDF images and global hemodynamic data were obtained immediately before and 4 h, 24 h, and 48 h after the first administration of the drug. RESULTS: Already 4 h after administration, there was a significant improvement in the proportion of perfused small (<20 µm) vessels (PPV) (from 78 [72-84] to 89 [82-94]%, P < 0.05) and the microvascular flow index (MFI) (from 2.25 [1.95-2.50] to 2.80 [2.39-2.95] points, P < 0.05), which persisted over subsequent hours. Large vessel perfusion remained constant. There was no correlation between changes in the PPV and changes in the mean arterial pressure (R2 0.02, P = 0.50), cardiac output (R2 0.004, P = 0.85), or central or mixed venous oxygen saturation (R2 0.03, P = 0.53). CONCLUSIONS: In patients with severe heart failure, introduction of angiotensin antagonist therapy was associated with an early improvement in the microcirculation that persisted over subsequent hours. The microcirculatory effects were independent of global hemodynamic variables. The improvement in microcirculatory perfusion observed with angiotensin inhibitors in patients with severe heart failure may partially explain the beneficial clinical effects of this intervention in such patients.
Assuntos
Angiotensina II/sangue , Antagonistas de Receptores de Angiotensina/uso terapêutico , Inibidores da Enzima Conversora de Angiotensina/uso terapêutico , Insuficiência Cardíaca/sangue , Insuficiência Cardíaca/tratamento farmacológico , Idoso , Captopril/uso terapêutico , Feminino , Humanos , Masculino , Microcirculação/efeitos dos fármacos , Pessoa de Meia-Idade , Estudos Prospectivos , Sistema Renina-Angiotensina/efeitos dos fármacosRESUMO
BACKGROUND: Delirium features can vary greatly depending on the postoperative population studied; however, most studies focus only on high-risk patients. Describing the impact of delirium and risk factors in mixed populations can help in the development of preventive actions. METHODS: The occurrence of delirium was evaluated prospectively in 465 consecutive nonventilated postoperative patients admitted to a surgical intensive care unit (SICU) using the confusion assessment method (CAM). Patients with and without delirium were compared. A multiple logistic regression was performed to identify the main risk factors for delirium in the first 24 h of admission to the SICU and the main predictors of outcomes. RESULTS: Delirium was diagnosed in 43 (9.2%) individuals and was more frequent on the second and third days of admission. The presence of delirium resulted in longer lengths of SICU and hospital stays [6 days (3-13) vs. 2 days (1-3), p < 0.001 and 26 days (12-39) vs. 6 days (3-13), p <0.001, respectively], as well as higher hospital and SICU mortality rates [16.3% vs. 4.0%, p = 0.004 and 6.5% vs. 1.7%, p = 0.042, respectively]. The risk factors for delirium were age (odds ratio (OR), 1.04 [1.02-1.07]), Acute Physiologic Score (APS; OR, 1.11 [1.04-1.2]), emergency surgery (OR, 8.05 [3.58-18.06]), the use of benzodiazepines (OR, 2.28 [1.04-5.00]), and trauma (OR, 6.16 [4.1-6.5]). CONCLUSIONS: Delirium negatively impacts postoperative nonventilated patients. Risk factors can be used to detect high-risk patients in a mixed population of SICU patients.
RESUMO
Severe sepsis is frequently associated with microcirculatory abnormalities despite seemingly adequate hemodynamic resuscitation. As increased serum angiotensin II levels may play a role in this dysfunction, we evaluated the microcirculatory effects of enalaprilat in an experimental model of septic shock. One hour after injection of 1.5 g/kg body weight of feces into the abdominal cavity, 16 adult female anesthetized, mechanically ventilated sheep were randomized to receive 2.5 mg enalaprilat or saline. When fluid-resistant hypotension (mean arterial pressure, <65 mmHg) developed, norepinephrine was given up to a maximal dose of 3 µg·kg(-1)·min(-1). The sublingual microcirculation was evaluated using sidestream dark-field videomicroscopy. A cutoff of 20 µm was used to differentiate small and large vessels. Experiments were pursued until the sheep's spontaneous death or for a maximum of 30 h. There were progressive and significant reductions in the proportion of small perfused vessels and in the microvascular flow index for small vessels (both P < 0.01 for trend) during shock and the first 2 h of norepinephrine infusion in the placebo group, which were prevented by the administration of enalaprilat. There were no differences between treated and placebo groups in global hemodynamic variables, time to shock or median survival time (21.8 [18.6-28.8] vs. 22.9 [21.8-30.0] h; P = 0.45). However, oxygen exchange was worse (PaO2/FiO2 ratio, 224 [128-297] vs. 332 [187-450]; P < 0.05), and creatinine concentrations increased more in the treated group (from 0.51 [0.42-0.75] to 1.19 [0.64-1.50] mg·dL(-1); P = 0.04) than in the control group (from 0.55 [0.45-0.62] to 0.78 [0.46-1.78] mg·dL(-1); P = 0.12), Enalaprilat therefore prevented the worsening of sublingual microcirculatory variables in this fluid-resuscitated, hyperdynamic model of septic shock, without significant effect on arterial pressure, but with a possible deleterious effect on renal and lung function.
Assuntos
Enalaprilato/uso terapêutico , Microcirculação/efeitos dos fármacos , Soalho Bucal/irrigação sanguínea , Choque Séptico/tratamento farmacológico , Angiotensina II/antagonistas & inibidores , Animais , Feminino , Hidratação , Placebos , Distribuição Aleatória , Carneiro DomésticoRESUMO
OBJETIVOS: Esse estudo objetiva avaliar o prognóstico de pacientes cirróticos admitidos em Unidade de Terapia Intensiva. MÉTODOS: Realizou-se coorte prospectiva de pacientes cirróticos internados entre junho de 1999 a setembro de 2004 em dois centros de tratamento intensivo. Foram coletadas informações demográficas, comorbidades, diagnósticos, sinais vitais, exames laboratoriais, escores prognósticos e o desfecho no centro de tratamento intensivo (CTI) e no hospital. Os pacientes foram divididos em grupos distintos: não cirúrgicos, cirurgias não hepáticas, cirurgias para hipertensão portal, cirurgias hepáticas, transplante hepático e cirurgias de urgência. RESULTADOS: Foram estudados 304 pacientes cirróticos, sendo 190 (62,5 por cento) do sexo masculino. A mediana da idade foi de 54 (47-61) anos. A letalidade global no CTI e no hospital foi de 29,3 e 39,8 por cento, respectivamente, mais elevadas do que as observadas nos demais pacientes admitidos no período do estudo (19,6 e 28,3 por cento; p<0,001). Os pacientes não cirúrgicos e os submetidos a cirurgia de urgência apresentaram alta letalidade, tanto no CTI (64,3 e 65,4 por cento) quanto hospitalar (80,4 e 76,9 por cento). Os fatores relacionados à letalidade no hospital foram [razão de chances (intervalo de confiança a 95 por cento)]: pressão arterial média [0,985 (0,974-0,997)]; ventilação mecânica às 24 h de admissão [4,080 (1,990-8,364)]; infecção confirmada às 24 h de admissão [7,899 (2,814-22,175)]; insuficiência renal aguda [5,509 (1,708-17,766)] e escore APACHE II (pontos) [1,078 (1,017-1,143)]. CONCLUSÕES: Pacientes cirróticos apresentaram letalidade mais elevada que os demais pacientes admitidos na terapia intensiva, particularmente aqueles admitidos após cirurgias de urgência e os não cirúrgicos.
OBJECTIVE: This study aimed to evaluate the outcome of cirrhotic patients admitted to Intensive Care Unit. METHODS: We conducted a prospective cohort of cirrhotic patients admitted to two intensive care unit between June 1999 to September 2004. We collected demographic, comorbid conditions, diagnosis, vital signs, laboratory data, prognostic scores and evolution in intensive care unit and hospital. The patients were divided in groups: non surgical, non liver surgery, surgery for portal hypertension, liver surgery, liver transplantation, and urgent surgery. RESULTS: We studied 304 patients, which 190 (62.5 percent) were male. The median of age was 54 (47-61) years. The mortality rate in intensive care unit and hospital were 29.3 and 39.8 percent, respectively, more elevated than in the other patients admitted critically ill patients (19.6 and 28.3 percent; p<0.001). Non surgical patients and those submitted to urgent surgery presented high mortality rate in the intensive care unit (64.3 and 65.4 percent) and in the hospital (80.4 and 76.9 percent). The variables related to hospital mortality were [Odds ratio (confidence interval 95 percent)]: mean arterial pressure [0.985 (0.974-0.997)]; mechanical ventilation in the first 24 h [4.080 (1.990-8.364)]; confirmed infection in the first 24 h [7.899 (2.814-22.175)]; acute renal failure [5.509 (1.708-17.766)] and APACHE II score (points) [1.078 (1.017-1.143)]. CONCLUSIONS: Cirrhotic patients had higher mortality rate compared to non cirrhotic critically ill patients. Those admitted after urgent surgery and non surgical had higher mortality rate.
RESUMO
IMPORTANCE OF THE FIELD: Severe sepsis is characterized by relative hypotension associated with a high cardiac output, peripheral vasodilation, and organ dysfunction. The renin-angiotensin-aldosterone system (RAAS) is primarily activated to increase blood pressure, but recently potential pro-inflammatory effects of angiotensin II have attracted interest because of the reported association between angiotensin II levels and organ failure and mortality in sepsis. RAAS antagonists could represent a new therapeutic option in this setting. AREAS COVERED IN THIS REVIEW: The role of RAAS activation in severe sepsis and septic shock, and the potential benefits (and risks) of using RAAS antagonists. WHAT THE READER WILL GAIN: Insight into RAAS function in severe sepsis and the potential for RAAS inhibitors to be used as an adjunctive therapy in patients with severe sepsis, with discussion of promising results from animal models of sepsis. TAKE HOME MESSAGE: Use of RAAS antagonists is an emerging therapeutic option in severe sepsis because these agents may reduce endothelial damage, organ failure, and mortality. However, timing of administration of RAAS antagonists is important because reduced RAAS function may contribute to refractive hypotension later on in septic shock and benefits of RAAS antagonists seem to be restricted to the early phases of sepsis.
Assuntos
Sistema Renina-Angiotensina/efeitos dos fármacos , Sepse/tratamento farmacológico , Angiotensina II/fisiologia , Bloqueadores do Receptor Tipo 1 de Angiotensina II/uso terapêutico , Inibidores da Enzima Conversora de Angiotensina/uso terapêutico , Hemodinâmica/efeitos dos fármacos , Hemodinâmica/fisiologia , Humanos , Microcirculação/efeitos dos fármacos , Microcirculação/fisiologia , Receptor Tipo 2 de Angiotensina/metabolismo , Receptor Tipo 2 de Angiotensina/fisiologia , Sistema Renina-Angiotensina/fisiologia , Sepse/fisiopatologiaRESUMO
OBJECTIVE: This study aimed to evaluate the outcome of cirrhotic patients admitted to Intensive Care Unit. METHODS: We conducted a prospective cohort of cirrhotic patients admitted to two intensive care unit between June 1999 to September 2004. We collected demographic, comorbid conditions, diagnosis, vital signs, laboratory data, prognostic scores and evolution in intensive care unit and hospital. The patients were divided in groups: non surgical, non liver surgery, surgery for portal hypertension, liver surgery, liver transplantation, and urgent surgery. RESULTS: We studied 304 patients, which 190 (62.5%) were male. The median of age was 54 (47-61) years. The mortality rate in intensive care unit and hospital were 29.3 and 39.8%, respectively, more elevated than in the other patients admitted critically ill patients (19.6 and 28.3%; p<0.001). Non surgical patients and those submitted to urgent surgery presented high mortality rate in the intensive care unit (64.3 and 65.4%) and in the hospital (80.4 and 76.9%). The variables related to hospital mortality were [Odds ratio (confidence interval 95%)]: mean arterial pressure [0.985 (0.974-0.997)]; mechanical ventilation in the first 24 h [4.080 (1.990-8.364)]; confirmed infection in the first 24 h [7.899 (2.814-22.175)]; acute renal failure [5.509 (1.708-17.766)] and APACHE II score (points) [1.078 (1.017-1.143)]. CONCLUSIONS: Cirrhotic patients had higher mortality rate compared to non cirrhotic critically ill patients. Those admitted after urgent surgery and non surgical had higher mortality rate.
RESUMO
INTRODUCTION: Adrenal failure (AF) is associated with increased mortality in septic patients. Nonetheless, there is no agreement regarding the best diagnostic criteria for AF. We compared the diagnosis of AF considering different baseline total cortisol cutoff values and Deltamax values after low (1 microg) and high (249 microg) doses of corticotropin, we analyzed the impact of serum albumin on AF identification and we correlated laboratorial AF with norepinephrine removal. METHODS: A prospective noninterventional study was performed in an intensive care unit from May 2002 to May 2005, including septic shock patients over 18 years old without previous steroid usage. After measurement of serum albumin and baseline total cortisol, the patients were sequentially submitted to 1 microg and 249 microg corticotropin tests with a 60-minute interval between doses. Post-stimuli cortisol levels were drawn 60 minutes after each test (cortisol 60 and cortisol 120). The cortisol 60 and cortisol 120 values minus baseline were called Deltamax1 and Deltamax249, respectively. Adrenal failure was defined as Deltamax249 < or = 9 microg/dl or baseline cortisol < or = 10 microg/dl. Other baseline cortisol cutoff values referred to as AF in other studies (< or =15, < or =20, < or =25 and < or =34 mug/dl) were compared with Deltamax249 < or = 9 microg/dl and serum albumin influence. Norepinephrine removal was compared with the baseline cortisol values and Deltamax249 values. RESULTS: We enrolled 102 patients (43 male). AF was diagnosed in 22.5% (23/102). Patients with albumin < or =2.5 g/dl presented a lower baseline total cortisol level (15.5 microg/dl vs 22.4 microg/dl, P = 0.04) and a higher frequency of baseline cortisol < or =25 microg/dl (84% vs 58.3%, P = 0.05) than those with albumin > 2.5 g/dl. The Deltamax249 levels and Deltamax249 < or = 9, however, were not affected by serum albumin (14.5 microg/dl vs 18.8 microg/dl, P = 0.48 and 24% vs 25%, P = 1.0). Baseline cortisol < or = 23.6 microg/dl was the most accurate diagnostic threshold to determine norepinephrine removal according to the receiver operating characteristic curve. CONCLUSION: AF was identified in 22.5% of the studied population. Since Deltamax249 < or = 9 microg/dl results were not affected by serum albumin and since the baseline serum total cortisol varied directly with albumin levels, we propose that Deltamax249 < or = 9 microg/dl, which means Deltamax after high corticotropin dose may be a better option for AF diagnosis whenever measurement of free cortisol is not available. Baseline cortisol < or =23.6 microg/dl was the best value for predicting norepinephrine removal in patients without corticosteroid treatment.
Assuntos
Testes de Função do Córtex Suprarrenal , Insuficiência Adrenal/epidemiologia , Insuficiência Adrenal/fisiopatologia , Choque Séptico/epidemiologia , Choque Séptico/fisiopatologia , Córtex Suprarrenal/fisiopatologia , Testes de Função do Córtex Suprarrenal/métodos , Insuficiência Adrenal/sangue , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Albumina Sérica/metabolismo , Choque Séptico/sangueRESUMO
JUSTIFICATIVA E OBJETIVOS: A transfusão de concentrado de hemácias (CHA) é muito freqüente no centro de tratamento intensivo (CTI), mas as conseqüências da anemia nos pacientes gravemente enfermos ainda são obscuras. Os objetivos desse estudo foram avaliar a freqüência, as indicações, os limiares transfusionais e o prognóstico dos pacientes criticamente enfermos que receberam CHA. MÉTODO: Estudo prospectivo de coorte realizado no CTI médico-cirúrgico de um Hospital Universitário durante 16 meses. Foram coletados dados demográficos, clínicos e os relacionados a transfusão de CHA. Regressão logística binária foi utilizada após as análises univariadas. RESULTADOS: Dos 698 pacientes internados, 244 (35 por cento) foram transfundidos com CHA. Os pacientes clínicos e em pós-operatório de urgência foram mais transfundidos. Os limiares transfusionais foram: hematócrito = 22,8 por cento ± 4,5 por cento e hemoglobina = 7,9 ± 1,4 g/dL. Os pacientes transfundidos receberam em média 4,4 ± 3,7 CHA e apresentaram maior letalidade no CTI (39,8 por cento versus 13,2 por cento; p < 0,0001) e no hospital (48,8 por cento versus 20,3 por cento; p < 0,0001). A letalidade correlacionou-se com o número de CHA transfundidos (R² = 0,91). Na análise multivariada, os fatores relacionados com a necessidade de transfusão foram cirrose hepática, ventilação mecânica (VM), tipo e duração da internação no CTI, hematócrito e escore SAPS II. Os fatores independentes relacionados à letalidade hospitalar foram: VM, número de transfusões de CHA > 5 unidades e escore SAPS II. CONCLUSÕES: A transfusão de CHA é freqüente no CTI, particularmente nos pacientes internados por problemas clínicos e após cirurgias de emergência, com internação prolongada, em VM e com cirrose hepática. O limiar transfusional observado foi mais baixo que aquele assinalado pela literatura. A transfusão de CHA foi associada com maior letalidade.
BACKGROUND AND OBJECTIVES: Packed red blood cell (PRBC) transfusion is frequent in intensive care unit (ICU). However, the consequences of anemia in ICU patients are poorly understood. Our aim was to evaluate the prevalence, indications, pre-transfusion hematocrit and hemoglobin levels, and outcomes of ICU patients transfused with PRBC. METHODS: Prospective cohort study conducted at a medical-surgical ICU of a teaching hospital during a 16-month period. Patients' demographic, clinical, laboratory and transfusion-related data were collected. Logistic regression was used after univariate analyses. RESULTS: A total of 698 patients were evaluated and 244 (35 percent) received PRBC, mainly within the first four days of ICU (82.4 percent). Transfusion was more frequent in medical and emergency surgical patients. The mean pre-transfusion hematocrit and hemoglobin were 22.8 percent ± 4.5 percent and 7.9 ± 1.4 g/dL, respectively. Transfused patients received 4.4 ± 3.7 PRBC during ICU stay and 2.2 ± 1 PRBC at each transfusion. The ICU (39.8 percent versus 13.2 percent; p < 0.0001) and hospital (48.8 percent versus 20.3 percent; p < 0.0001) mortality rates were higher in transfused patients. Mortality increased as the number of transfused PRBC increased (R² = 0.91). In logistic regression, predictive factors for PRBC transfusion were hepatic cirrhosis, mechanical ventilation (MV), type and duration of ICU admission, and hematocrit. The independent factors associated to hospital mortality were MV, transfusions of more than five PRBC and SAPS II score. CONCLUSIONS: PRBC transfusions are frequent in ICU patients, especially in those with medical and emergency surgical complications, longer ICU stay, and hepatic cirrhosis and in need of MV. Pre-transfusion hemoglobin levels were lower than those previously reported. In our study, PRBC transfusion was associated with increased mortality.
Assuntos
Humanos , Masculino , Feminino , Estudos Epidemiológicos , Unidades de Terapia Intensiva , Transfusão de Eritrócitos/efeitos adversos , Transfusão de Eritrócitos/mortalidadeRESUMO
OBJETIVO: Determinar prevalência de pneumonia associada à ventilação mecânica em unidade de terapia intensiva, fatores associados e evolução. MÉTODOS: Foram avaliados 278 pacientes sob ventilação mecânica por mais de 24 horas prospectivamente em hospital universitário. RESULTADOS: Desenvolveram a doença 38,1 por cento dos pacientes, 35,7 casos/1.000 dias de ventilação mecânica: 45,3 por cento por bacilos gram negativos, Pseudomonas aeruginosa (22 por cento) o mais comum e 43,4 por cento por germes multi-resistentes. O grupo com pneumonia associada à ventilação mecânica teve maiores tempos de ventilação mecânica, desmame, permanência no hospital e na unidade de terapia intensiva (p < 0,001); atelectasia, síndrome do desconforto respiratório agudo, pneumotórax, sinusite, traqueobronquite e infecção multirresistente foram mais comuns (p < 0,05). Letalidades na unidade de terapia intensiva e no hospital foram semelhantes. Fatores associados à doença (razão de chances; intervalo de confiança 95 por cento): sinusite aguda (38,8; 3,4 - 441), ventilação mecânica >10 dias (7,7; 4,1 - 14,2), imunodepressão (4,3; 1,3 - 14,3), síndrome do desconforto respiratório agudo (3,5; 1,4 - 9,0), atelectasia (3,0; 1,2 - 7,3), parada cardiorrespiratória (0,18; 0,05 - 0,66) e hemorragia digestiva alta (0,07; 0,009 - 0,62]. Fatores associados ao óbito hospitalar: insuficiência renal crônica (26,1; 1,9 - 350,7), admissão prévia na unidade de terapia intensiva (15,6; 1,6 - 152,0), simplified acute physiologic score II > 50 pontos (11,9; 3,4 - 42,0) e idade > 55 anos (4,4; 1,6 - 12,3). CONCLUSÃO: A pneumonia associada à ventilação mecânica aumentou tempos de ventilação mecânica, permanência na unidade de terapia intensiva e no hospital, número de complicações, mas não a letalidade.
OBJECTIVE: To determine the prevalence of ventilator-associated pneumonia in an intensive care unit, as well as to identify related factors and characterize patient evolution. METHODS: This study evaluated 278 patients on mechanical ventilation for more than 24 hours in a university hospital. RESULTS: Ventilator-associated pneumonia developed in 38.1 percent of the patients, translating to 35.7 cases/1000 ventilator-days: 45.3 percent were caused by gram-negative agents (Pseudomonas aeruginosa accounting for 22 percent); and multidrug resistant organisms were identified in 43.4 percent. In the ventilator-associated pneumonia group, time on mechanical ventilation, time to mechanical ventilation weaning, hospital stays and intensive care unit stays were all longer (p < 0.001). In addition, atelectasis, acute respiratory distress syndrome, pneumothorax, sinusitis, tracheobronchitis and infection with multidrug resistant organisms were more common in the ventilator-associated pneumonia group (p < 0.05). Mortality rates in the intensive care unit were comparable to those observed in the hospital infirmary. Associations between ventilator-associated pneumonia and various factors are expressed as odds ratios and 95 percent confidence intervals: acute sinusitis (38.8; 3.4-441); > 10 days on mechanical ventilation (7.7; 4.1-14.2); immunosuppression (4.3; 1.3-14.3); acute respiratory distress syndrome (3.5; 1.4-9.0); atelectasis (3.0; 1.2-7.3); cardiac arrest (0.18; 0.05-0.66); and upper gastrointestinal tract bleeding (0.07; 0.009-0.62). The variables found to be associated with in-hospital death were as follows: chronic renal failure (26.1; 1.9-350.7); previous intensive care unit admission (15.6; 1.6-152.0); simplified acute physiologic score II > 50 (11.9; 3.4-42.0); and age > 55 years (4.4; 1.6-12.3). CONCLUSION: Ventilator-associated pneumonia increased the time on mechanical ventilation and the number of complications, as well as the length...
Assuntos
Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Hospitais Universitários/estatística & dados numéricos , Unidades de Terapia Intensiva/estatística & dados numéricos , Pneumonia Associada à Ventilação Mecânica/epidemiologia , Métodos Epidemiológicos , Tempo de Internação , Prognóstico , Pneumonia Associada à Ventilação Mecânica/microbiologiaRESUMO
JUSTIFICATIVA E OBJETIVOS: A evolução dos pacientes cuja internação é negada nos centros de terapia intensiva (CTI) é pouco conhecida. Os objetivos deste estudo foram comparar as características dos pacientes internados com aqueles que não foram internados em CTI e identificar os fatores associados com o processo de triagem para a internação. MÉTODO: Foi realizado um estudo do tipo coorte prospectiva e observacional durante 26 meses. Os dados dos pacientes foram coletados através de um formulário padronizado para a solicitação de internação no CTI. Os desfechos de interesse do estudo foram a internação no CTI e a evolução hospitalar. RESULTADOS: Foram estudados 455 pacientes dos quais 254 (56 por cento) foram internados e 201 (44 por cento) não; a maioria destes, por falta de vagas (82 por cento). Os pacientes não internados apresentaram maior letalidade (85 por cento versus 61 por cento; p < 0,001). Na análise multivariada, foram identificados os seguintes fatores associados à não internação dos pacientes no CTI [razão de chances, (intervalo de confiança 95 por cento)]: neoplasia metastática [5,6(1,7-18,7)], pressão arterial sistólica < 90 mmHg [5,2(3,0-8,8)], idade >70 anos [4,0(2,4-6,5)], cirrose hepática [3,7(1,8-7,5)], e escala de coma de Glasgow < 5 [3,6(1,9-6,9)]. Por outro lado, os pacientes em ventilação mecânica [0,5(0,3-0,7)] e aqueles com cardiopatia isquêmica [0,1(0,03-0,6)] apresentaram maior probabilidade de internação no CTI. CONCLUSÕES: A recusa de pacientes no CTI é freqüente e ocorre geralmente por falta de vagas. Os pacientes não internados apresentaram maior letalidade. Foram identificadas características dos pacientes que estão associadas ao processo de seleção de pacientes para internação na unidade de terapia intensiva.
BACKGROUND AND OBJECTIVES: Information on the outcomes of patients who were refused to the ICU is limited. The aims of this study were to compare the clinical characteristics of patients who were admitted with those of patients who were refused to the ICU and to identify clinical parameters associated with triage procedures. METHODS: Observational prospective cohort study. The following data were collected using a standard questionnaire: comorbidities, acute illness, vital status, laboratory data and APACHE II score. The end-points of interest were admission to the ICU and vital status at hospital discharge. RESULTS: A total of 455 patients were studied; 254 (56 percent) were admitted and 201 (44 percent) were not. The main reason for the refuse of admission was the lack of ICU beds (82 percent). Patients who were not admitted had a higher mortality (85 percent vs. 61 percent; p < 0.001). In multivariable analysis, the following variables were associated to non-admission [odds ratio, (95 percent confidence interval)]: metastatic cancer [5.6(1.7-18.7)], arterial systolic pressure < 90 mmHg [5.2(3.0-8.8)], age > 70 years [4.0(2.4-6.5)], hepatic cirrhosis [3.7(1.8-7.6)], and Glasgow coma scale < 5 [3.6(1.9-6.9)]. The variables associated with ICU admission were: mechanical ventilation [0.5(0.3-0.7)] and acute coronary syndromes [0.1(0.03-0.6)]. CONCLUSIONS: Refusal of ICU admission is frequent and generally as a consequence of ICU beds shortage. Patients who were not admitted had a higher mortality. Clinical characteristics associated with the refusal of admission were identified suggesting that they are used in clinical decision-making for ICU triage.
Assuntos
Humanos , Masculino , Feminino , APACHE , Hospitalização , Unidades de Terapia Intensiva/provisão & distribuiçãoRESUMO
OBJECTIVE: To determine the prevalence of ventilator-associated pneumonia in an intensive care unit, as well as to identify related factors and characterize patient evolution. METHODS: This study evaluated 278 patients on mechanical ventilation for more than 24 hours in a university hospital. RESULTS: Ventilator-associated pneumonia developed in 38.1% of the patients, translating to 35.7 cases/1000 ventilator-days: 45.3% were caused by gram-negative agents (Pseudomonas aeruginosa accounting for 22%); and multidrug resistant organisms were identified in 43.4%. In the ventilator-associated pneumonia group, time on mechanical ventilation, time to mechanical ventilation weaning, hospital stays and intensive care unit stays were all longer (p < 0.001). In addition, atelectasis, acute respiratory distress syndrome, pneumothorax, sinusitis, tracheobronchitis and infection with multidrug resistant organisms were more common in the ventilator-associated pneumonia group (p < 0.05). Mortality rates in the intensive care unit were comparable to those observed in the hospital infirmary. Associations between ventilator-associated pneumonia and various factors are expressed as odds ratios and 95% confidence intervals: acute sinusitis (38.8; 3.4-441); > 10 days on mechanical ventilation (7.7; 4.1-14.2); immunosuppression (4.3; 1.3-14.3); acute respiratory distress syndrome (3.5; 1.4-9.0); atelectasis (3.0; 1.2-7.3); cardiac arrest (0.18; 0.05-0.66); and upper gastrointestinal tract bleeding (0.07; 0.009-0.62). The variables found to be associated with in-hospital death were as follows: chronic renal failure (26.1; 1.9-350.7); previous intensive care unit admission (15.6; 1.6-152.0); simplified acute physiologic score II > 50 (11.9; 3.4-42.0); and age > 55 years (4.4; 1.6-12.3). CONCLUSION: Ventilator-associated pneumonia increased the time on mechanical ventilation and the number of complications, as well as the length of intensive care unit and hospital stays, but did not affect mortality rates.
Assuntos
Hospitais Universitários/estatística & dados numéricos , Unidades de Terapia Intensiva/estatística & dados numéricos , Pneumonia Associada à Ventilação Mecânica/epidemiologia , Adulto , Idoso , Métodos Epidemiológicos , Feminino , Humanos , Tempo de Internação , Masculino , Pessoa de Meia-Idade , Pneumonia Associada à Ventilação Mecânica/microbiologia , PrognósticoRESUMO
BACKGROUND AND OBJECTIVES: Packed red blood cell (PRBC) transfusion is frequent in intensive care unit (ICU). However, the consequences of anemia in ICU patients are poorly understood. Our aim was to evaluate the prevalence, indications, pre-transfusion hematocrit and hemoglobin levels, and outcomes of ICU patients transfused with PRBC. METHODS: Prospective cohort study conducted at a medical-surgical ICU of a teaching hospital during a 16-month period. Patients' demographic, clinical, laboratory and transfusion-related data were collected. Logistic regression was used after univariate analyses. RESULTS: A total of 698 patients were evaluated and 244 (35%) received PRBC, mainly within the first four days of ICU (82.4%). Transfusion was more frequent in medical and emergency surgical patients. The mean pre-transfusion hematocrit and hemoglobin were 22.8% ± 4.5% and 7.9 ± 1.4 g/dL, respectively. Transfused patients received 4.4 ± 3.7 PRBC during ICU stay and 2.2 ± 1 PRBC at each transfusion. The ICU (39.8% versus 13.2%; p < 0.0001) and hospital (48.8% versus 20.3%; p < 0.0001) mortality rates were higher in transfused patients. Mortality increased as the number of transfused PRBC increased (R² = 0.91). In logistic regression, predictive factors for PRBC transfusion were hepatic cirrhosis, mechanical ventilation (MV), type and duration of ICU admission, and hematocrit. The independent factors associated to hospital mortality were MV, transfusions of more than five PRBC and SAPS II score. CONCLUSIONS: PRBC transfusions are frequent in ICU patients, especially in those with medical and emergency surgical complications, longer ICU stay, and hepatic cirrhosis and in need of MV. Pre-transfusion hemoglobin levels were lower than those previously reported. In our study, PRBC transfusion was associated with increased mortality.
RESUMO
BACKGROUND AND OBJECTIVES: Information on the outcomes of patients who were refused to the ICU is limited. The aims of this study were to compare the clinical characteristics of patients who were admitted with those of patients who were refused to the ICU and to identify clinical parameters associated with triage procedures. METHODS: Observational prospective cohort study. The following data were collected using a standard questionnaire: comorbidities, acute illness, vital status, laboratory data and APACHE II score. The end-points of interest were admission to the ICU and vital status at hospital discharge. RESULTS: A total of 455 patients were studied; 254 (56%) were admitted and 201 (44%) were not. The main reason for the refuse of admission was the lack of ICU beds (82%). Patients who were not admitted had a higher mortality (85% vs. 61%; p < 0.001). In multivariable analysis, the following variables were associated to non-admission [odds ratio, (95% confidence interval)]: metastatic cancer [5.6(1.7-18.7)], arterial systolic pressure < 90 mmHg [5.2(3.0-8.8)], age > 70 years [4.0(2.4-6.5)], hepatic cirrhosis [3.7(1.8-7.6)], and Glasgow coma scale < 5 [3.6(1.9-6.9)]. The variables associated with ICU admission were: mechanical ventilation [0.5(0.3-0.7)] and acute coronary syndromes [0.1(0.03-0.6)]. CONCLUSIONS: Refusal of ICU admission is frequent and generally as a consequence of ICU beds shortage. Patients who were not admitted had a higher mortality. Clinical characteristics associated with the refusal of admission were identified suggesting that they are used in clinical decision-making for ICU triage.
RESUMO
Methicillin-resistant Staphylococcus aureus (MRSA) is a frequent cause of infection after orthotopic liver transplantation (OLT). Colonization with MRSA is associated with a higher risk of infection. Previous studies have shown a high prevalence of MRSA colonization among OLT candidates. However, the risk of colonization with MRSA after OLT is still unclear. The objective of this study was to estimate the incidence and the factors associated with colonization with MRSA after OLT. This was a prospective cohort study including patients submitted to OLT between the years 2000 and 2002. Surveillance cultures of nasal swab specimens were performed within the 1st 72 hours of hospital admission and, subsequently, on weeks 2, 6, 13, and 26. Patients whose baseline cultures revealed nasal carriage of MRSA were excluded. A total of 60 patients were included in the study. The median follow-up was 72 days. A total of 9 patients (15%) became colonized. In multiple logistic regression analyses, the use of a urinary catheter for > or =5 days (P = .006), postoperative bleeding at the surgical site (P = .009), and preoperative use of fluoroquinolones (P = .08) were associated with a higher risk of colonization. Patients without any of these risk factors did not become colonized. In conclusion, nasal carriage of MRSA is frequently acquired after OLT. Periodic postoperative screening for MRSA carriage should be an integral component in programs designed to reduce nosocomial MRSA transmission in these patients. Further studies are needed to set up and validate a predictive model that could allow targeting postoperative screening to high-risk OLT recipients.
Assuntos
Transplante de Fígado , Nariz/microbiologia , Complicações Pós-Operatórias/epidemiologia , Infecções Estafilocócicas/epidemiologia , Staphylococcus aureus/isolamento & purificação , Feminino , Humanos , Incidência , Tempo de Internação , Modelos Logísticos , Masculino , Resistência a Meticilina , Pessoa de Meia-Idade , Staphylococcus aureus/efeitos dos fármacosAssuntos
Masculino , Feminino , Humanos , Cuidados Críticos , Cuidados Críticos/métodos , Cuidados Críticos/tendências , Cirurgia Geral , Medicina , TerapêuticaRESUMO
Objetivo: Avaliar a evolucao do tratamento da Sindrome de Guillain-BarT (SGB) em pacientes internados em terapia intensiva. Local: Unidade medico-cirurgica do Centro de Tratamento Intensivo do Hospital Universitario Clementino Fraga Filho da Universidade Federal do Rio de Janeiro. Tipo de Estudo: Coorte de insercao (revisao de prontuarios) de todos os pacientes internados com SGB no periodo de 1984 a 1995. Dados clinicos, o criterio diagnostico, tratamento efetuado e complicacoes foram coletados e analisados. O ponto final do estudo foi a evolutpo hospitalar (altas ou obitos). A analise estatistica: Teste de Fisher exato. Um valor de < 0,05 foi considerado estatisticamente significativo. Principais resultados: Foram avaliados 26 pacientes com SGB. Dividindo os pacientes em dois periodos: de 1984 a 1990 (Grupo 1 - 14 pacientes) e de 1991 a 1995 (Grupo 2 - 12 pacientes) observamos que: a) no primeiro perfodo os pacientes apresentaram mais complicacoes cardiovasculares relacionadas a disautonomia - bradicardia, assistolia, hipo e hipertensao (12/14 - 85,7 por cento vs. 5/12 - 41,6 por cento; p =, 0,02); b) no segundo os pacientes utilizaram mais plasmaferese, imunoglobulinas ou liquorferese (11/12 - 91,6 por cento vs. 1/14 - 7,1 por cento; p < 0,001); c) a letalidade no primeiro periodo foi de 11/14 - 78,6 por cento; jß no segundo periodo npo foram observados =bitos (p < 0,001); d) o tipo de assistencia ventilatoria empregada foi diferente - no primeiro perfodo utilizaram-se protese cicladas a pressao e a volume (14/14 - 100 por cento) enquanto que no segundo periodo a maioria fez uso de proteses microprocessadas (9/11 - 81,8 por cento) - p < 0,01; e) a incidencia de sepse, choque septico, hiperglicemia, pneumotorax, atelectasia e sindrome do desconforto respiratorio agudo foram similares nos dois periodos. Conclusoes: O tratamento da SGB com medidas imunomodulatorias e utilizando-se assistencia ventilatoria atraves de respiradores microprocessados sao extremamente eficazes, diminuindo as complicacoes cardiovasculares da disautonomia e a letalidade.
Assuntos
Humanos , Masculino , Feminino , Adulto , Polirradiculoneuropatia/terapia , Polirradiculoneuropatia/complicações , Polirradiculoneuropatia/mortalidadeRESUMO
Objetivo: Identificar os fatores relacionados à letalidade dos pacientes internados em terapia intensiva com diagnóstico clínico de doença de Weil. Local: Unidade Médico-Cirúrgica do Centro de Tratamento Intensivo (CTI) de um Hospital Universitário terciário urbano na Cidade do Rio de Janeiro - Brasil. Tipo de estudo: Coorte de início (revisäo de prontuários) sendo coletados dados clínicos, epidemiológicos, laboratoriais, bacteriológicos, terapêutica empregada e os escores prognósticos APACHE II, APACHE III, SAPS, SAPS II, MPM II (0) MPM II (24) e Odin. Pacientes: Todos os pacientes internados com doença de Weil no CTI. Período de estudo: De julho de 1981 a novembro de 1993. Análise estatística: Testes univariados - Teste de Fisher exato e qui-quadrado com correçäo de Yates para variáveis categóricas, na dependência do tamanho amostral, t-Student para variáveis contínuas paramétricas. Mann-Whitney rank sum para variáveis ordinais, regressäo linear, coeficiente de correlaçäo de Pearson, intervalo de confiança a 95 por cento. Teorema de Bayes e Teste Multivariado - Regressäo Linear Logística (RLL). Um valor de p<0,05 foi considerado significativo. Ponto final do estudo: Evoluçäo hospitalar (altas ou óbitos). Intervençöes: Nenhuma. Principais resultados: Foram revistos 44 prontuários observando-se letalidade hospitalar de 72,7 por cento (32/44). As seguintes variáveis foram estatisticamente relacionadas à letalidade: 1) sexo masculino (p<0,02); 2) número de disfunçöes de órgäos e sistemas (MODS) no 1( dia (p=0,002) e no 2( dia (p=0,03) de CTI; 3) disfunçäo respiratória (p=0,01); 4) hemorragia digestiva alta (HDA) no 1( dia (p=0,02) e no 2( dia (p=0,01) de CTI); 5) método dialítico empregado (hemodiálise x diálise peritoneal x sem necessidade de diálise (p=0,03); 6) evoluçäo com insuficiência renal aguda (IRA) oligúrica (p<0,02); 7) uso de altas doses de dopamina (>10 mcg/Kg/min) para manter a pressäo arterial (p=0,04); 8) exames de laboratório: trombocitopenia (p<0,01), acidose (p<0,05) e fósforo sérico elevado (p<0,05). Através da RLL (stepwise approach) foram selecionados três variáveis: 1) n( de MODS, 2) evoluçäo da IRA (oligúrica x nao-oligúrica) e 3) tipo de tratamento dialítico empregado. O modelo denominado de Weil apresentou as seguintes estimativas de sensibilidade, especificidade e classificaçäo correta de 91,67 por cento, 93,75 por cento e 93,18 por cento, respectivamente, utilizando-se o ponto de coorte em 50 por cento. A área sobre a curva ROC foi de 0,975. Tais números säo muito melhores do que aqueles apresentados pelos demais escores prognósticos. Observamos pior desempenho dos escores preditivos mais recentes. Conclusöes: A doença de Weil apresenta alta letalidade. O prognóstico é determinado principalmente pelo desenvolvimento de disfunçäo de múltiplos órgäos e sistemas, sendo...